tiprankstipranks
Organogenesis Holdings Inc (ORGO)
NASDAQ:ORGO

Organogenesis Holdings (ORGO) Financial Statements

384 Followers

Organogenesis Holdings Financial Overview

Organogenesis Holdings's market cap is currently ―. The company's EPS TTM is $0.036; its P/E ratio is 71.12; Organogenesis Holdings is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 108.53M$ 117.32M$ 107.64M$ 114.52M$ 116.86M
Gross Profit$ 82.74M$ 117.32M$ 81.03M$ 87.41M$ 90.68M
EBIT$ 8.08M$ 9.77M$ -3.98M$ 7.72M$ 1.78M
EBITDA-$ 15.18M$ 1.89M$ 12.28M$ 6.29M
Net Income Common Stockholders$ 3.17M$ 5.32M$ -2.97M$ 6.49M$ 215.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 98.23M$ 89.51M$ 89.42M$ 103.29M$ 107.25M
Total Assets$ 462.65M$ 450.31M$ 446.11M$ 449.36M$ 457.27M
Total Debt$ 122.81M$ 122.67M$ 122.35M$ 123.79M$ 130.71M
Net Debt$ 24.59M$ 33.16M$ 32.94M$ 20.50M$ 23.46M
Total Liabilities$ 185.78M$ 179.03M$ 182.41M$ 183.69M$ 200.94M
Stockholders Equity$ 276.87M$ 271.28M$ 263.70M$ 265.67M$ 256.33M
Cash Flow-
Free Cash Flow-$ 1.15M$ -12.64M$ -2.86M$ -4.95M
Operating Cash Flow$ 16.73M$ 8.65M$ -5.08M$ 7.80M$ 5.45M
Investing Cash Flow$ -5.98M$ -7.50M$ -7.56M$ -10.66M$ -10.40M
Financing Cash Flow$ -1.44M$ -1.05M$ -1.24M$ -1.88M$ 26.00K
Currency in USD

Organogenesis Holdings Earnings and Revenue History

Organogenesis Holdings Debt to Assets

Organogenesis Holdings Cash Flow

Organogenesis Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis